Graticule Asia Macro Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-161,000
Closed -$13.3M 105
2017
Q2
$13.3M Buy
+161,000
New +$13.1M 0.63% 34
2016
Q4
Sell
-84,500
Closed -$6.78M 126
2016
Q3
$6.78M Sell
84,500
-46,500
-35% -$3.72M 0.48% 39
2016
Q2
$10.3M Buy
+131,000
New +$9.86M 1.07% 18
2015
Q4
Sell
-123,000
Closed -$10.3M 186
2015
Q3
$10.3M Sell
123,000
-3,500
-3% -$295K 1.2% 18
2015
Q2
$10.6M Buy
+126,500
New +$9.64M 0.51% 35

Other funds holding LLY

Graticule Asia Macro Advisors's LLY Position: Q2 2021 in Review

Graticule Asia Macro Advisors sold out of Eli Lilly (LLY) in Q2 2021, closing a stake of 17,390 shares — an estimated $3.25M sold.

Graticule Asia Macro Advisors first reported a position in LLY in Q3 2015 and held it in 10 quarters. The position peaked at $20.5M in Q3 2015. 2,021 funds tracked by Wall St. Rank hold LLY as of Q2 2021.

  • Graticule Asia Macro Advisors reported no remaining Eli Lilly position as of Q2 2021 after selling out during the quarter.
  • Graticule Asia Macro Advisors sold 17,390 Eli Lilly shares in Q2 2021, an estimated $3.25M.
  • Graticule Asia Macro Advisors first reported a position in Eli Lilly in Q3 2015 and held it in 10 quarters.
  • Graticule Asia Macro Advisors's Eli Lilly position peaked at $20.5M in Q3 2015.
  • 2,021 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2021.

Based on Graticule Asia Macro Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.